-
Travere Therapeutics (NASDAQ:TVTX) Earns "Overweight" Rating from Cantor Fitzgerald
Source: Buzz FX / 22 Feb 2025 12:56:17 America/Chicago
Travere Therapeutics (NASDAQ:TVTX) Earns "Overweight" Rating from Cantor Fitzgerald Written by MarketBeat February 22, 2025 Share Link copied to clipboard. Travere Therapeutics ( NASDAQ:TVTX - Get Free Report ) 's stock had its "overweight"
Read more...